NEOSPHERE Trademark
Trademark Overview
On Tuesday, July 5, 2022, a trademark application was filed for NEOSPHERE with the United States Patent and Trademark Office. The USPTO has given the NEOSPHERE trademark a serial number of 97489090. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Wednesday, November 20, 2024. This trademark is owned by NEOsphere Biotechnologies GmbH. The NEOSPHERE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Analysis in the field of molecular biology; Consultancy relating to pharmaceutical research and development; Consultancy in the field of pharmaceutical research; Pharmaceutical product evaluation; Biochemistry research services; Biochemical analysis; Biochemistry services in the nature of mass spectrometry based proteomics and proteomic data analysis; Biochemical research and analysis; Biological analysis; Biological research and development services; Biological research; Biological research and analysis; Biological research, clinical research and medical research; Biomedical research services; Biotechnological research relating to industry; Research relating to biotechnology; Computer programming in the medical field; Computer software programming services; Medical research laboratory services; Biological research laboratory services; Services for assessing the efficiency of pharmaceuticals being testing of pharmaceuticals; Biotechnology testing; Analysis of human serum for medical re...
General Information
| Serial Number | 97489090 |
| Word Mark | NEOSPHERE |
| Filing Date | Tuesday, July 5, 2022 |
| Status | 654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED |
| Status Date | Wednesday, November 20, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Analysis in the field of molecular biology; Consultancy relating to pharmaceutical research and development; Consultancy in the field of pharmaceutical research; Pharmaceutical product evaluation; Biochemistry research services; Biochemical analysis; Biochemistry services in the nature of mass spectrometry based proteomics and proteomic data analysis; Biochemical research and analysis; Biological analysis; Biological research and development services; Biological research; Biological research and analysis; Biological research, clinical research and medical research; Biomedical research services; Biotechnological research relating to industry; Research relating to biotechnology; Computer programming in the medical field; Computer software programming services; Medical research laboratory services; Biological research laboratory services; Services for assessing the efficiency of pharmaceuticals being testing of pharmaceuticals; Biotechnology testing; Analysis of human serum for medical research; Analysis of human tissues for medical research; Conducting of scientific studies and research in the field of targeted protein degradation and targeted protein stabilization and related data analysis; Development of pharmaceutical drug preparations and medicines; Development and creation of computer programmes for data processing; Computer software development for others; Development of data bases; Pharmaceutical products development; computer software development; Design and development of data processing programs; Research and development of vaccines and medicines; Research relating to molecular sciences; Research on the subject of pharmaceuticals; Research and development services in the field of immunology; Research and development in the pharmaceutical and biotechnology fields; Biochemical research and development; Research and development for the pharmaceutical industry; Research and development in the field of microorganisms and cells; Clinical research in the field of targeted protein degradation and targeted protein stabilization and related data analysis; Medical and scientific research, namely, conducting clinical trials for others; Laboratory research services relating to pharmaceuticals; Medical research; Medical research in the field of oncology; Pharmaceutical drug development services; Pharmaceutical research services; Pharmaceutical research and development; Preparation of biological samples for research purposes; Preparation of biological samples for analysis in research laboratories; Preparation of biological samples for testing and analysis in research laboratories; Scientific and technological services, namely, scientific analysis in the field of targeted protein degradation and targeted protein stabilization and related data analysis; Scientific research in the field of drug discovery; Scientific research relating to biology; Scientific research and development; Scientific research for medical purposes in the area of cancerous diseases; Scientific investigations for medical purposes |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, July 25, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | NEOsphere Biotechnologies GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Planegg 82152
DE |
Trademark Events
| Event Date | Event Description |
| Friday, July 8, 2022 | NEW APPLICATION ENTERED |
| Monday, July 25, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, August 31, 2022 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Tuesday, October 11, 2022 | ASSIGNED TO LIE |
| Tuesday, October 11, 2022 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
| Wednesday, April 19, 2023 | ASSIGNED TO EXAMINER |
| Monday, April 24, 2023 | NON-FINAL ACTION WRITTEN |
| Monday, April 24, 2023 | NON-FINAL ACTION E-MAILED |
| Monday, April 24, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, July 19, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, July 19, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, July 20, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, August 16, 2023 | SUSPENSION LETTER WRITTEN |
| Wednesday, August 16, 2023 | LETTER OF SUSPENSION E-MAILED |
| Wednesday, August 16, 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Friday, February 16, 2024 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Friday, August 30, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, November 20, 2024 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
